Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years.
Concolino P, Costella A, Capoluongo E. Cancer Genet. 2016 Jan-Feb;209(1-2):36-41. doi: 10.1016/j.cancergen.2015.12.002. Review. PMID: 26767918 https://www.ncbi.nlm.nih.gov/pubmed/26767918
Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
Cavalli T, Giudici F, Santi R, Nesi G, Brandi ML, Tonelli F. Fam Cancer. 2016 Oct;15(4):645-9. https://www.ncbi.nlm.nih.gov/pubmed/27071757
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR,
Surgery in MEN 2A Patients Older Than 5 Years with Micro-MTC: Outcome at Long-term Follow-up.
Tonelli F, Giudici F, Marcucci T, Cavalli T, Spini S, Gheri RG, Brandi ML. Otolaryngol Head Neck Surg. 155(5):787-789, 2016. https://www.ncbi.nlm.nih.gov/pubmed/27406704
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
Giusti F, Cianferotti L, Gronchi G, Cioppi F, Masi L, Faggiano A, Colao A, Ferolla P, Brandi ML. Endocrine. 2016 Jun;52(3):495-506. Epub 2015 Jul 30.
An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells.
Luzi E, Marini F, Ciuffi S, Galli G, Brandi ML. Mol Biosyst. 2016 May 24;12(6):1922-8. https://www.ncbi.nlm.nih.gov/pubmed/27098433
Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome.
Tonelli F, Biagini C, Giudici F, Cioppi F, Brandi ML. Fam Cancer. 2016 Jan;15(1):133-8 https://www.ncbi.nlm.nih.gov/pubmed/26394783
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story.
Marini F, Giusti F, Brandi ML. World J Exp Med. 5(2):124-9, 2015. https://www.ncbi.nlm.nih.gov/pubmed/25992327 Free PMC Article
Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM, Dekkers OM, Pieterman CR, Kluijfhout WP, Hermus AR, Pereira AM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, de Herder
